Australia markets closed
  • ALL ORDS

    7,078.90
    -28.20 (-0.40%)
     
  • ASX 200

    6,800.40
    -23.30 (-0.34%)
     
  • AUD/USD

    0.7717
    -0.0050 (-0.65%)
     
  • OIL

    51.98
    -1.15 (-2.16%)
     
  • GOLD

    1,855.50
    -10.40 (-0.56%)
     
  • BTC-AUD

    42,520.18
    +1,317.53 (+3.20%)
     
  • CMC Crypto 200

    651.44
    +41.45 (+6.79%)
     
  • AUD/EUR

    0.6336
    -0.0044 (-0.69%)
     
  • AUD/NZD

    1.0737
    -0.0017 (-0.16%)
     
  • NZX 50

    13,333.43
    +221.23 (+1.69%)
     
  • NASDAQ

    13,366.40
    -38.59 (-0.29%)
     
  • FTSE

    6,695.07
    -20.35 (-0.30%)
     
  • Dow Jones

    30,996.98
    -179.03 (-0.57%)
     
  • DAX

    13,873.97
    -32.70 (-0.24%)
     
  • Hang Seng

    29,447.85
    -479.91 (-1.60%)
     
  • NIKKEI 225

    28,631.45
    -125.41 (-0.44%)
     

India Stem Cell Market to 2026 by Product Type (Adult; Induced Pluripotent; Human Embryonic; Others), & Application (Regenerative Medicine Vs. Drug Discovery & Development) - ResearchAndMarkets.com

·3-min read

The "India Stem Cell Market by Product Type (Adult; Induced Pluripotent; Human Embryonic; Others), by Application (Regenerative Medicine Vs. Drug Discovery & Development), by Technology, by Region, Competition Forecast & Opportunities, FY 2026" report has been added to ResearchAndMarkets.com's offering.

The Indian Stem Cell Market is expected to grow at over 12% CAGR during FY 2021 - FY 2026.

Continuous advancements in tissue engineering is one of the prime factors boosting the Indian Stem Cell Market. Development of regenerative medicines coupled with growing cases of chronic and genetic diseases across the country are some of the other factors anticipated to drive the growth of the stem cell market during the forecast years. Moreover, availability of funds from the government and certain organizations is estimated to bode well for the growth of the Indian Stem Cell Market over the next five years.

The Indian Stem Cell Market is segmented based on product type, application, technology, and region. Based on product type, the market can be categorized into adult, induced pluripotent, human embryonic and others. Out of these, the adult stem cells segment dominated the market until FY 2020 and is further expected to maintain its leading position in the market during the forecast period as well on account of reduced contamination risk associated with sub-culturing.

Moreover, its compatibility with the human body is expected to drive the segment growth over the coming years. Additionally, less requirement for production labor is boosting the growth of adult stem cells segment.

Major players operating in the Indian Stem Cell Market include Reliance Life Sciences, LifeCell International Private Limited, Cryobanks International India Private Limited, Cordlife India, StemCyte India Therapeutics Private Limited, ReeLabs Private Limited, Stempeutics Research Private Limited, among others.

The companies are focusing on extensive research and developments activities in order to stay competitive in the market. Other competitive strategies include formation of alliances and partnerships.

Years considered for this report:

  • Historical Years: FY 2016 - FY 2019

  • Base Year: FY 2020

  • Estimated Year: FY 2021

  • Forecast Period: FY 2022 - FY 2026

Report Scope:

In this report, the Indian Stem Cell Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Market, By Product Type:

  • Adult

  • Induced Pluripotent

  • Human Embryonic

  • Others

Market, By Application:

  • Regenerative Medicine

  • Drug Discovery & Development

Market, By Technology:

  • Cell Acquisition

  • Cell Production

  • Cryopreservation

  • Expansion & Subculture

Market, By Region:

  • North

  • East

  • West

  • South

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Indian Stem Cell Market.

Companies Mentioned

  • Reliance Life Sciences

  • LifeCell International Private Limited

  • Cryobanks International India Private Limited

  • Cordlife India

  • StemCyte India Therapeutics Private Limited

  • ReeLabs Private Limited

  • Stempeutics Research Private Limited

For more information about this report visit https://www.researchandmarkets.com/r/9dhnfz

View source version on businesswire.com: https://www.businesswire.com/news/home/20201127005496/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900